Gyroscope Capital Management Group, LLC Abb Vie Inc. Transaction History

Gyroscope Capital Management Group, LLC

$440 Million
Q3 2023

A detailed history of Gyroscope Capital Management Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gyroscope Capital Management Group, LLC holds 34,989 shares of ABBV stock, worth $6.3 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares

34,989

Previous 32,164 8.78%

Holding current value

$6.3 Million

Previous $4.33 Million 20.36%

% of portfolio

1.19%

Previous 0.99%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $377,391 - $436,886	2,825 Added 8.78%	34,989 $5.22 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $22,129 - $27,538	167 Added 0.52%	32,164 $4.33 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $12,436 - $14,322	86 Added 0.27%	31,997 $5.1 Million
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $4.41 Million - $5.29 Million	31,911 New	31,911 $5.16 Million
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $250,761 - $311,125	-1,900 Reduced 8.68%	20,000 $3.24 Million
Q1 2021 Apr 19, 2021	SELL	$102.3 - $112.62 $116,110 - $127,823	-1,135 Reduced 4.93%	21,900 $2.37 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $276,241 - $372,955	3,432 Added 17.51%	23,035 $2.47 Million
Q3 2020 Oct 14, 2020	SELL	$85.91 - $100.83 $461,422 - $541,557	-5,371 Reduced 21.51%	19,603 $1.72 Million
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $438,312 - $586,527	5,974 Added 31.44%	24,974 $2.45 Million
Q4 2019 Jan 29, 2020	SELL	$72.13 - $90.25 $34,117 - $42,688	-473 Reduced 2.43%	19,000 $1.68 Million
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $883,253 - $1.04 Million	-11,450 Reduced 37.03%	19,473 $1.58 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $2.41 Million - $2.97 Million	30,923 New	30,923 $2.85 Million
Q3 2018 Oct 10, 2018	SELL	$88.91 - $98.84 $6.07 Million - $6.75 Million	-68,271 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $324,644 - $384,127	3,616 Added 5.59%	68,271 $6.33 Million
Q1 2018 May 21, 2018	SELL	$92.01 - $123.21 $241,250 - $323,056	-2,622 Reduced 3.9%	64,655 $6.12 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $78,544 - $86,130	877 Added 1.32%	67,277 $6.51 Million
Q3 2017 Nov 16, 2017	SELL	$69.85 - $89.22 $1.26 Million - $1.61 Million	-18,066 Reduced 21.39%	66,400 $5.9 Million
Q2 2017 Aug 15, 2017	BUY	N/A	84,466	84,466 $6.13 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyroscope Capital Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gyroscope Capital Management Group, LLC with notifications on news.

Account

Gyroscope Capital Management Group, LLC Abb Vie Inc. Transaction History